ENVOY MEDICAL INC. -

Envoy Medical Reports Fourth Quarter and Full Year 2023 Financial Results

02 Apr 2024 08:00:18 By Nasdaq GlobeNewswire

Envoy Medical to Participate in the 36th Annual ROTH Conference

12 Mar 2024 10:52:36 By Nasdaq GlobeNewswire

Envoy Medical Secures Up To $10 Million Term Debt Financing to Advance Upcoming Clinical Trial

04 Mar 2024 09:20:00 By Nasdaq GlobeNewswire

Newly Introduced Bipartisan Bill Seeks to Clarify Fully Implanted Active Middle Ear Hearing Devices as Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage

07 Feb 2024 09:00:00 By Nasdaq GlobeNewswire

Envoy Medical CEO Brent Lucas Interviewed by Leading Healthcare Podcast Medical Alley

05 Feb 2024 11:00:00 By Nasdaq GlobeNewswire

Envoy Medical Announces Three Additional Patents for Implantable Cochlear Systems

22 Jan 2024 09:00:00 By Nasdaq GlobeNewswire

Envoy Medical to Host Fireside Chat Event December 7

04 Dec 2023 08:15:00 By Nasdaq GlobeNewswire

Envoy Medical Provides Third Quarter 2023 Financial Results and Business Update

20 Nov 2023 07:30:56 By Nasdaq GlobeNewswire

Envoy Medical Announces Publication of Additional Patent for Implantable Cochlear Systems

10 Nov 2023 09:00:00 By Nasdaq GlobeNewswire

Envoy Medical to Present at the Emerging Growth Virtual Conference November 1

24 Oct 2023 09:00:00 By Nasdaq GlobeNewswire

New Clinical Publication Reports First Three Patients in Early Feasibility Trial for Envoy Medical’s Fully Implanted Cochlear Device

19 Oct 2023 08:00:00 By Nasdaq GlobeNewswire